minimally invasive procedure. Pain, unspecified
Conditions
Interventions
Intervention 1: Intervention group: receiving oral midazolam (Daroupakhsh company, Tehran, Iran, 15 mg/3 ml concentration) 0.3 mg/kg one time before doing venipuncture. Intervention 2: Intervention gr
50 mg/ ml concentration) 50 mg/kg one time before doing venipuncture.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 5 Years
Inclusion criteria
Inclusion criteria: Age between 1-5 years old. Awareness of patients. Not to need for emergent IV access. Patients in class I of American anesthesiology association (without physiologic disorders). Consent of parents or guardians to enroll in the study.
Exclusion criteria
Exclusion criteria: patients with underlying disease affecting on their vessels like patients under chemotherapy and so on
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success in intravenous access. Timepoint: at the end of procedure. Method of measurement: implementation of peripheral IV access.;Number of attempts for IV line access. Timepoint: at the end of procedure. Method of measurement: counting number of try to insert the needle in the body.;Duration of IV line access. Timepoint: at the end of procedure. Method of measurement: the time between starting setup to achieve IV line. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery time, time from IV line access to complete consciousness. Timepoint: after complete consciousness of patient. Method of measurement: calculating the time by operator. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Saeidinia
Mashhad University of Medical Sciences
Outcome results
None listed